CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $31.1M, above the global median of $16.24M
- FinancialsAltman Z-Score 5.02: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.24%Below 5Y avg (0.46%)
Annual Rate
CNY 0.02Paid annual
Payout Ratio
11.7%Sustainable
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.26BCNY631.59M · vs all stocks (USD)
Trailing P/E
83.40xRevenue (TTM)
910.98MCNY135.10M · vs all stocks (USD)
Profit Margin
5.76%Beta
0.1860xvs all stocks
52-Week Change
-13.56%vs all stocks
Market Capitalization
4.26BCNY631.59M · vs all stocks (USD)
Enterprise Value
3.80BCNY563.80M · vs all stocks (USD)
Trailing P/E
83.40xForward P/E
25.27xPEG Ratio
4.95xPrice to Sales (TTM)
4.68xPrice to Book (MRQ)
2.31xEnterprise to Revenue
4.17xEnterprise to EBITDA
30.75xGross Margin
37.13%Profit Margin
5.76%Operating Margin
10.60%Return on Assets (TTM)
1.72%Return on Equity (TTM)
2.68%Revenue (TTM)
910.98MCNY135.10M · vs all stocks (USD)
Revenue per Share (TTM)
1.78CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-2.10%Gross Profit (TTM)
313.28MCNY46.46M · vs all stocks (USD)
EBITDA (TTM)
172.41MCNY25.57M · vs all stocks (USD)
Net Income (TTM)
52.49MCNY7.78M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
16.90%Operating Cash Flow (TTM)
231.83MCNY34.38M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
209.74MCNY31.10M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0200CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.24%vs all stocks
5-Year Average Dividend Yield
0.46%vs all stocks
Payout Ratio
11.67%Minority Interest (Equity)
22.79MCNYFY2025 · Dec 31, 2025Revenue
915.53MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
603.42MCNYFY2025 · Dec 31, 2025Gross Profit
312.12MCNYFY2025 · Dec 31, 2025Operating Income
125.93MCNY18.67M · vs all stocks (USD)
Pre-tax Income
65.03MCNYFY2025 · Dec 31, 2025Income Tax Expense
18.08MCNYFY2025 · Dec 31, 2025Net Income
46.96MCNYFY2025 · Dec 31, 2025EBIT
65.80MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
172.41MCNYFY2025 · Dec 31, 2025Research & Development
24.56MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
76.52MCNYFY2025 · Dec 31, 2025Other Operating Expenses
18.43MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.90MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
770.72KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0964CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0964CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
510.45MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
510.45MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
46.96MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
2.25MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
8.51MCNYFY2025 · Dec 31, 2025Free Cash Flow
-9.77MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
524.49MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
46.96MCNYFY2025 · Dec 31, 2025Other Non-cash Items
4.55MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-86.74MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
43.74MCNYFY2025 · Dec 31, 2025Capital Expenditures
-18.28MCNYFY2025 · Dec 31, 2025Purchase of Investments
-20.00MCNYFY2025 · Dec 31, 2025Other Investing Activity
-18.87KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-38.30MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
16.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-23.90MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-7.02MCNYFY2025 · Dec 31, 2025Other Financing Charges
-928.89KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-15.85MCNYFY2025 · Dec 31, 2025Shares Outstanding
510.66MSharesUpdated Aug 19, 2026Float Shares
189.17MSharesUpdated Aug 19, 2026% Held by Insiders
65.94%vs all stocks
% Held by Institutions
0.40%vs all stocks
Total Cash (MRQ)
565.24MCNY83.83M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.11CNYUpdated Aug 19, 2026Total Debt (MRQ)
28.68MCNY4.25M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0154xCurrent Ratio (MRQ)
3.04xBook Value per Share (MRQ)
3.61CNYUpdated Aug 19, 2026Total Assets
2.55BCNY377.79M · vs all stocks (USD)
Total Current Assets
1.33BCNYFY2025 · Dec 31, 2025Total Liabilities
692.03MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.21BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
251.41MCNYFY2025 · Dec 31, 2025Total Current Liabilities
440.62MCNYFY2025 · Dec 31, 2025Cash
524.49MCNYFY2025 · Dec 31, 2025Cash Equivalents
153.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
524.49MCNYFY2025 · Dec 31, 2025Accounts Receivable
301.93MCNYFY2025 · Dec 31, 2025Inventory
289.84MCNYFY2025 · Dec 31, 2025Accounts Payable
263.63MCNYFY2025 · Dec 31, 2025Short-term Debt
37.78MCNYFY2025 · Dec 31, 2025Other Current Liabilities
23.88MCNYFY2025 · Dec 31, 2025Long-term Debt
7.71MCNYFY2025 · Dec 31, 2025Common Stock (Book)
510.66MCNYFY2025 · Dec 31, 2025Retained Earnings
851.22MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.86BCNY275.17M · vs all stocks (USD)
52-Week Low
6.63CNYUpdated Aug 19, 202652-Week High
11.02CNYUpdated Aug 19, 202652-Week Change
-13.56%vs all stocks
Beta
0.1860xvs all stocks
50-Day MA
7.59CNYUpdated Aug 19, 2026200-Day MA
8.42CNYUpdated Aug 19, 2026Avg 10-Day Volume
11.80MSharesUpdated Aug 19, 2026Avg 30-Day Volume
7.73MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.1000CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.02: safe zoneNotable
Altman Z-Score: 5.02
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $31.1M, above the global median of $16.24MNotable
Levered free cash flow (USD): 31,104,795.547Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Gkht Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ironwood Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jinling Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cerus Corporation
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Kinetic Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MiMedx Group, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tibet Weixinkang Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lionco Pharmaceutical Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou AGS Medtech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hefei Lifeon Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow